Joshua Stahl

Joshua Stahl is the President and CEO of InterVenn Biosciences, with a tenure beginning in September 2023, and serves as a member of the Board of Directors. Previously, Joshua took a break from October 2021 to September 2023 and served as Chief Executive Officer at Invitae from October 2020 to October 2021. Joshua's extensive experience includes key leadership roles at ArcherDX, Inc., where a range of positions was held from Chief Scientific Officer to Vice President of R&D. Joshua also contributed to Enzymatics and Thermo Fisher Scientific, focusing on driving innovation and project execution, particularly in Next Generation Sequencing. Educational qualifications include a Master of Business Administration from the University of Colorado Boulder and a Master of Science in Biochemistry from the same institution, complemented by a Bachelor's degree in Biochemistry and Molecular Biology from West Virginia University.